115 related articles for article (PubMed ID: 23150708)
1. Primary follicular lymphoma of the GI tract: an increasingly recognized entity.
Jain VK; Bystricky B; Wotherspoon AC; Chau I; Cunningham D
J Clin Oncol; 2012 Dec; 30(36):e370-2. PubMed ID: 23150708
[No Abstract] [Full Text] [Related]
2. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.
Askeland G
Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446
[No Abstract] [Full Text] [Related]
3. [Watch and wait in follicular lymphoma: time for change?].
Hiddemann W
Dtsch Med Wochenschr; 2012 Oct; 137(42):2181-2. PubMed ID: 23055363
[No Abstract] [Full Text] [Related]
4. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
[No Abstract] [Full Text] [Related]
5. Bilateral conjunctival follicular lymphoma in a child.
Wall PB; Traboulsi EI; Hsi ED; Singh AD
J AAPOS; 2015 Apr; 19(2):183-5. PubMed ID: 25824110
[TBL] [Abstract][Full Text] [Related]
6. Rapid-onset, prolonged bone marrow failure following rituximab therapy of follicular lymphoma.
Debatin L; Schmitt-Graeff A; Veelken H
Onkologie; 2011; 34(6):322-4. PubMed ID: 21625186
[No Abstract] [Full Text] [Related]
7. Primary gastrointestinal follicular lymphoma: single-center 12-year experiences.
Na YJ; Kim ER; Kim SJ; Kim WS; Ko YH; Son HJ
Hepatogastroenterology; 2012 May; 59(115):751-3. PubMed ID: 22020908
[TBL] [Abstract][Full Text] [Related]
8. [Standard therapy and research questions in follicular lymphoma].
Ishizawa K
Rinsho Ketsueki; 2012 Oct; 53(10):1624-33. PubMed ID: 23037735
[No Abstract] [Full Text] [Related]
9. [Pathogenesis and treatment of follicular lymphoma].
Nishikori M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():477-81. PubMed ID: 23134002
[No Abstract] [Full Text] [Related]
10. The challenge of recurrent follicular lymphoma.
Tomás JF
Lancet Oncol; 2011 Aug; 12(8):714-6. PubMed ID: 21724461
[No Abstract] [Full Text] [Related]
11. Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.
Sanchez-Gonzalez B; Gimeno E; Garcia-Pallarols F; Ancochea A; Salar A
Leuk Lymphoma; 2014 Oct; 55(10):2384-6. PubMed ID: 24601815
[No Abstract] [Full Text] [Related]
12. Rituximab-related urticarial reaction overlying primary cutaneous follicle centre lymphoma: histological appearance and pathophysiological hypotheses.
Ingen-Housz-Oro S; Ortonne N; Chosidow O
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):976-8. PubMed ID: 24206369
[No Abstract] [Full Text] [Related]
13. Biology and treatment of follicular lymphoma.
Piccaluga PP; Sapienza MR; Agostinelli C; Sagramoso C; Mannu C; Sabattini E; Zinzani PL; Pileri SA
Expert Rev Hematol; 2009 Oct; 2(5):533-47. PubMed ID: 21083019
[TBL] [Abstract][Full Text] [Related]
14. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
15. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
16. A polycyclic annular erythematous plaque on the trunk: a quiz. Annular primary cutaneous follicle centre lymphoma.
Lemeray J; Guillot B; Dereure O
Acta Derm Venereol; 2012 Mar; 92(2):221-3. PubMed ID: 22169968
[No Abstract] [Full Text] [Related]
17. Rituximab maintenance therapy for follicular lymphoma.
Haines I
Lancet; 2011 Apr; 377(9772):1151; author reply 1151-2. PubMed ID: 21459205
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of rituximab in follicular lymphoma.
Johnston KM; Bolbocean C; Connors J; Peacock S
Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):569-77. PubMed ID: 23140274
[TBL] [Abstract][Full Text] [Related]
19. Rituximab maintenance therapy of relapsed or refractory follicular lymphoma, with longer follow-up: no proven impact on survival.
Prescrire Int; 2012 Mar; 21(125):63. PubMed ID: 22428183
[TBL] [Abstract][Full Text] [Related]
20. NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients.
Doss S; Garrett Z; Sutcliffe F; Stevens A
Lancet Oncol; 2012 Feb; 13(2):128-30. PubMed ID: 22403811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
